drugset / Trial / NCT02602119

Intraoperative Imaging of Pulmonary Nodules by OTL38

NCT02602119 ↗

Phase 1 Completed 262 enrolled University of Pennsylvania
NaSingle-groupOpen-labelDiagnostic

Summary

The primary end-point of the study is to determine the sensitivity of OTL in identifying lung nodules when excited by an imaging probe. Investigators intend to enroll 300 lung cancer patients in this study. The study is focusing on patients presenting with suspected malignancies of the lung and pleura who are considered to be good surgical candidates.

Timeline

Start
2015-05
Primary completion
2022-05
Completion
2022-05

Drugs

EvaluationDrugModalityDoseRoute
Subject pafolacianine Diagnostic / imaging agent — Other

Indications